Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Martine Barkats"'
Autor:
Maria Grazia Biferi, Mathilde Cohen-Tannoudji, Andrea García-Silva, Olga Souto-Rodríguez, Irene Viéitez-González, Beatriz San-Millán-Tejado, Andrea Fernández-Carrera, Tania Pérez-Márquez, Susana Teijeira-Bautista, Soraya Barrera, Vanesa Domínguez, Thibaut Marais, África González-Fernández, Martine Barkats, Saida Ortolano
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 1-17 (2021)
Fabry disease is a rare X-linked disorder affecting α-galactosidase A, a rate-limiting enzyme in lysosomal catabolism of glycosphingolipids. Current treatments present important limitations, such as low half-life and limited distribution, which gene
Externí odkaz:
https://doaj.org/article/b2d13278a02c48deb45d598f9f6bd188
Autor:
Inger Lauritzen, Anaïs Bécot, Alexandre Bourgeois, Raphaëlle Pardossi-Piquard, Maria-Grazia Biferi, Martine Barkats, Fréderic Checler
Publikováno v:
Translational Neurodegeneration, Vol 8, Iss 1, Pp 1-17 (2019)
Abstract Background We recently demonstrated an endolysosomal accumulation of the β-secretase-derived APP C-terminal fragment (CTF) C99 in brains of Alzheimer disease (AD) mouse models. Moreover, we showed that the treatment with the γ-secretase in
Externí odkaz:
https://doaj.org/article/027cf11112fc4c188a93980afe965595
Autor:
Valerie Matagne, Yann Ehinger, Lydia Saidi, Ana Borges-Correia, Martine Barkats, Marc Bartoli, Laurent Villard, Jean-Christophe Roux
Publikováno v:
Neurobiology of Disease, Vol 99, Iss , Pp 1-11 (2017)
Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder that is primarily caused by mutations in the methyl CpG binding protein 2 gene (MECP2). RTT is the second most prevalent cause of intellectual disability in girls and there is curre
Externí odkaz:
https://doaj.org/article/dede79c42fc643918696c45b6461c7be
Autor:
Nicole Armbruster, Annalisa Lattanzi, Matthieu Jeavons, Laetitia Van Wittenberghe, Bernard Gjata, Thibaut Marais, Samia Martin, Alban Vignaud, Thomas Voit, Fulvio Mavilio, Martine Barkats, Ana Buj-Bello
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
Spinal muscular atrophy (SMA) is an autosomal recessive disease of variable severity caused by mutations in the SMN1 gene. Deficiency of the ubiquitous SMN function results in spinal cord α-motor neuron degeneration and proximal muscle weakness. Gen
Externí odkaz:
https://doaj.org/article/c3375dc222574ce59427a986034859f1
Autor:
Alexis-Pierre Bemelmans, Sandra Duqué, Christel Rivière, Stéphanie Astord, Mélissa Desrosiers, Thibault Marais, José-Alain Sahel, Thomas Voit, Martine Barkats
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61618 (2013)
Widespread gene delivery to the retina is an important challenge for the treatment of retinal diseases, such as retinal dystrophies. We and others have recently shown that the intravenous injection of a self-complementary (sc) AAV9 vector can direct
Externí odkaz:
https://doaj.org/article/e048910f81a046eda072ae57275f1bdd
Autor:
Valentin Jacquier, Manon Prévot, Thierry Gostan, Rémy Bordonné, Sofia Benkhelifa-Ziyyat, Martine Barkats, Johann Soret
Publikováno v:
RNA. 28:303-319
Spinal muscular atrophy (SMA) is a devastating neurodegenerative disease caused by reduced amounts of the ubiquitously expressed Survival of Motor Neuron (SMN) protein. In agreement with its crucial role in the biogenesis of spliceosomal snRNPs, SMN-
Autor:
Martine Barkats
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2020, 36 (2), pp.137-140. ⟨10.1051/medsci/2020010⟩
médecine/sciences, EDP Sciences, 2020, 36 (2), pp.137-140. ⟨10.1051/medsci/2020010⟩
International audience; Spinal muscular atrophy (SMA) is the most common genetic disease leading to infant mortality. This neuro-muscular disorder is caused by the loss or mutation of the telomeric copy of the ‘survival of motor neuron’ (Smn) gen
Autor:
Martine Barkats, Irene Viéitez-González, África González-Fernández, Mathilde Cohen-Tannoudji, Andrea Fernandez-Carrera, Beatriz San-Millán-Tejado, Maria Grazia Biferi, Vanesa Domínguez, Saida Ortolano, Susana Teijeira-Bautista, Olga Souto-Rodriguez, Tania Pérez-Márquez, Thibaut Marais, Soraya Barrera, Andrea Garcia-Silva
Publikováno v:
Investigo. Repositorio Institucional de la Universidade de Vigo
Universidade de Vigo (UVigo)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 1-17 (2021)
Universidade de Vigo (UVigo)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 1-17 (2021)
Fabry disease is a rare X-linked disorder affecting α-galactosidase A, a rate-limiting enzyme in lysosomal catabolism of glycosphingolipids. Current treatments present important limitations, such as low half-life and limited distribution, which gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2885db2614f355e811d45393c2dc42a5
https://linkinghub.elsevier.com/retrieve/pii/S2329050120302205
https://linkinghub.elsevier.com/retrieve/pii/S2329050120302205
Autor:
Martine, Barkats
Publikováno v:
Medecine sciences : M/S. 36(2)
Spinal muscular atrophy (SMA) is the most common genetic disease leading to infant mortality. This neuro-muscular disorder is caused by the loss or mutation of the telomeric copy of the 'survival of motor neuron' (Smn) gene, termed SMN1. Loss of SMN1
Autor:
Alexandre Bourgeois, Martine Barkats, Inger Lauritzen, Raphaëlle Pardossi-Piquard, Maria-Grazia Biferi, Frédéric Checler, Anaïs Bécot
Publikováno v:
Translational Neurodegeneration
Translational Neurodegeneration, [London] : BioMed Central, 2012-, 2019, 8 (1), ⟨10.1186/s40035-019-0176-6⟩
Translational Neurodegeneration, Vol 8, Iss 1, Pp 1-17 (2019)
Translational Neurodegeneration, [London] : BioMed Central, 2012-, 2019, 8, ⟨10.1186/s40035-019-0176-6⟩
Translational Neurodegeneration, [London] : BioMed Central, 2012-, 2019, 8 (1), ⟨10.1186/s40035-019-0176-6⟩
Translational Neurodegeneration, Vol 8, Iss 1, Pp 1-17 (2019)
Translational Neurodegeneration, [London] : BioMed Central, 2012-, 2019, 8, ⟨10.1186/s40035-019-0176-6⟩
BackgroundWe recently demonstrated an endolysosomal accumulation of the β-secretase-derived APP C-terminal fragment (CTF) C99 in brains of Alzheimer disease (AD) mouse models. Moreover, we showed that the treatment with the γ-secretase inhibitor (D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edfc8b0e8451b44f6d787dd526cb4f11
https://hal.archives-ouvertes.fr/hal-02556329
https://hal.archives-ouvertes.fr/hal-02556329